892493-16-2

Basic information

• Product Name: methyl 4-methyl-4-piperidinecarboxylate(SALTDATA: HCl)
• Synonyms: methyl 4-methyl-4-piperidinecarboxylate(SALTDATA: HCl);Methyl 4-Methylpiperidine-4-carboxylate;4-Methyl-piperidine-4-carboxylic acid methyl ester;4-Piperidinecarboxylic acid, 4-methyl-, methyl ester;methyl 4-methyl-4-piperidinecarboxylate
• CAS NO: 892493-16-2
• Molecular Formula: C₈H₁₅NO₂
• Molecular Weight: 157.2102
• Mol File: 892493-16-2.mol
• Article Data: 4

Chemical Properties

• Boiling Point: 200.2±33.0 °C(Predicted)
• Appearance: /
• Density: 0.991±0.06 g/cm3(Predicted)
• PKA: 10.02±0.10(Predicted)
• CAS DataBase Reference: methyl 4-methyl-4-piperidinecarboxylate(SALTDATA: HCl)(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 4-methyl-4-piperidinecarboxylate(SALTDATA: HCl)(892493-16-2)
• EPA Substance Registry System: methyl 4-methyl-4-piperidinecarboxylate(SALTDATA: HCl)(892493-16-2)

Safety Data

• Hazardous Substances Data: 892493-16-2(Hazardous Substances Data)

Upstream product

• 724790-59-4 4-methyl-piperidine-1,4-dicarboxylic acid 1-tert-butyl ester 4-methyl ester 

Downstream Products

• 919354-20-4 4-methylpiperidine-4-carboxylic acid hydrogen chloride salt 
• 162648-32-0 4-methylpiperidine-4-carboxylic acid 

Relevant articles and documents

Small molecule compound

The invention provides a small molecule compound. The small molecule compound is characterized in that the small molecule compound is a compound shown in a structural formula in the specification, ora stereoisomer, a geometric isomer, a tautomer, a racemate, a hydrate, a solvate, a metabolite, and a pharmaceutically acceptable salt or pro-drug thereof, wherein X1 and X2 are selected from carbon or nitrogen; Z is carbon or nitrogen; n1 is 0 and 1; n2 and n3 are the same or different, and are 0 or any natural numbers; a cyclic group represented by G is a saturated heterocyclic ring; any one orseveral hydrogen atoms on the saturated heterocyclic ring are substituted by R; and R is selected from hydrogen, halogen, alkyl, substituted alkyl, amino, amine group, substituted amine group, carboxyl, amido, substituted amido, ester group, substituted carbonyl, cycloalkyl, substituted cycloalkyl, heterocycloalkyl, substituted heterocycloalkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, substituted sulfonyl, and substituted sulfoxide group. The small molecule compound of the invention can be used to treat, prevent and alleviate autoimmune diseases and/or immune-related inflammatory skin diseases.

NEW PYRIDINE ANALOGUES

The present invention relates to certain new pyridin analogues of Formula (I) Chemical formula should be inserted here. Please see paper copy Formula (I) to processes for preparing such compounds, to their utility as P2Y12 inhibitors and as anti-trombotic agents etc, their use as medicaments in cardiovascular diseases as well as pharmaceutical compositions containing them.